HRCT Patterns for Systemic Sclerosis-Related Lung Disease
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
Recruiting
Observational Study
Systemic Sclerosis
Interstitial Lung Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Other
Who this trial is looking for
This trial is looking for patients with systemic sclerosis and related lung disease, known as interstitial lung disease. Participants will undergo an HRCT scan to help classify the lung disease based on its appearance.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with systemic sclerosis.
- I have interstitial lung disease seen on an HRCT chest scan.
You may not be able to join if
- I have an alternative diagnosis causing lung problems, like silicosis or lung cancer.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. Interstitial lung disease (ILD) concerns almost 50 % of SSc patients and represents the main cause of mortality. SSc-ILD is variable: from limited forms (with asymptomatic patients) to extensive lesions. Disease course in SSc-ILD is also highly variable: patients can experience st…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with systemic sclerosis according to 2013 ACR/EULAR criteria
* Patients with interstitial lung disease on HRCT chest
Exclusion Criteria:
* Patients with an alternative diagnosis of SSc-associated ILD (silicosis, sarcoidosis, lung cancer or other significant lung abn…
Contacts